Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer.

Recent advances in fluorescent metal nanoclusters have spurred tremendous interest in nanomedicine due to the ease of fabrication, excellent biocompatibility, and, more importantly, excellent wavelength-dependent tunability. Herein, we report our findings on fluorescent BSA-protected gold nanoclusters (AuNCs), ∼2 nm in size conjugated with Herceptin (AuNCs-Her), for specific targeting and nuclear localization in ErbB2 over-expressing breast cancer cells and tumor tissue as a novel fluorescent agent for simultaneous imaging and cancer therapy. More interestingly, we found that AuNCs-Her could escape the endolysosomal pathway and enter the nucleus of cancer cells to enhance the therapeutic efficacy of Herceptin. We elucidate the diffusion characteristics (diffusion time and number of diffusers) and concentration of the fluorescing clusters in the nucleus of live cells. Our findings also suggest that the nuclear localization effect of AuNCs-Her enhances the anticancer therapeutic efficacy of Herceptin as evidenced by the induction of DNA damage. This study not only discusses a new nanomaterial platform for nuclear delivery of drugs but also provides important insights on nuclear targeting for enhanced therapy.

[1]  Thomas Ried,et al.  Response to RAG-mediated V(D)J cleavage by NBS1 and γ-H2AX , 2000 .

[2]  Alexander M Seifalian,et al.  Fluorescence nanoparticles “quantum dots” as drug delivery system and their toxicity: a review , 2011, Journal of drug targeting.

[3]  Kemin Wang,et al.  Ultrasmall near-infrared gold nanoclusters for tumor fluorescence imaging in vivo. , 2010, Nanoscale.

[4]  Andrew A Berlin,et al.  Composite organic-inorganic nanoparticles as Raman labels for tissue analysis. , 2007, Nano letters.

[5]  Joseph Irudayaraj,et al.  Gold nanorod/Fe3O4 nanoparticle "nano-pearl-necklaces" for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. , 2009, Angewandte Chemie.

[6]  M. Moore,et al.  Getting across the nuclear pore complex. , 1999, Trends in cell biology.

[7]  Conroy Sun,et al.  Self-Assembled Coatings on Individual Monodisperse Magnetite Nanoparticles for Efficient Intracellular Uptake , 2004, Biomedical microdevices.

[8]  Lyndsay N Harris,et al.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Kute,et al.  DNA strand breaks and cell cycle perturbation in Herceptin treated breast cancer cell lines* , 2001, Breast Cancer Research and Treatment.

[10]  D. Jans,et al.  Regulation of Nuclear Transport: Central Role in Development and Transformation? , 2005, Traffic.

[11]  J. Nam,et al.  Lipid-gold-nanoparticle hybrid-based gene delivery. , 2008, Small.

[12]  Jianping Xie,et al.  Protein-directed synthesis of highly fluorescent gold nanoclusters. , 2009, Journal of the American Chemical Society.

[13]  David J. Robertson,et al.  Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[14]  R. Reilly,et al.  Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2-Amplified Human Breast Cancer Cells to the Auger Electron–Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab , 2010, Journal of Nuclear Medicine.

[15]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[16]  Wolfgang J. Parak,et al.  Synthesis and surface modification of highly fluorescent gold nanoclusters and their exploitation for cellular labeling , 2010, BiOS.

[17]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[18]  W. Webb,et al.  Fluorescence correlation spectroscopy: diagnostics for sparse molecules. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[20]  D. Taatjes,et al.  Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells. , 2001, Current medicinal chemistry.

[21]  P. Bastiaens,et al.  Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. , 1999, Trends in cell biology.

[22]  Xin Wang,et al.  High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. , 2010, ACS nano.

[23]  M. El-Sayed,et al.  Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. , 2010, Journal of the American Chemical Society.

[24]  M. Rubart,et al.  Two-photon microscopy of cells and tissue. , 2004, Circulation research.

[25]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[26]  Joseph Irudayaraj,et al.  Quantitative investigation of compartmentalized dynamics of ErbB2 targeting gold nanorods in live cells by single molecule spectroscopy. , 2009, ACS nano.

[27]  D. Jans,et al.  Nuclear drug delivery to target tumour cells. , 2009, European journal of pharmacology.

[28]  Yuhua Wang,et al.  Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Ajay Kumar,et al.  Nanocarriers for Cytosolic Drug and Gene Delivery in Cancer Therapy , 2011 .

[30]  N. Periasamy,et al.  Measuring size distribution in highly heterogeneous systems with fluorescence correlation spectroscopy. , 2003, Biophysical journal.

[31]  Thomas Ried,et al.  AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching , 2001, Nature.

[32]  Alexander F Schier,et al.  Molecular genetics of axis formation in zebrafish. , 2005, Annual review of genetics.

[33]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[34]  G. Alvisi,et al.  A Protein Kinase CK2 Site Flanking the Nuclear Targeting Signal Enhances Nuclear Transport of Human Cytomegalovirus ppUL44 , 2005, Traffic.

[35]  Karolin F Meyer,et al.  Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. , 2008, Bioconjugate chemistry.

[36]  R. Reilly,et al.  111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer , 2007, Journal of Nuclear Medicine.

[37]  Kostas Kostarelos,et al.  Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. , 2007, Nanomedicine.

[38]  S. Nair,et al.  Download details: IP Address: 203.199.213.66 , 2009 .

[39]  Elizabeth R Gillies,et al.  Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. , 2002, Journal of the American Chemical Society.

[40]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[41]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[42]  Wolfgang J. Parak,et al.  Synthesis, characterization, and bioconjugation of fluorescent gold nanoclusters toward biological labeling applications. , 2009, ACS nano.

[43]  K. Landfester,et al.  Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells. , 2009, Journal of controlled release : official journal of the Controlled Release Society.